Zachary Roberts - 04 Mar 2022 Form 4 Insider Report for Instil Bio, Inc. (TIL)

Reporting relationship: Chief Medical Officer
Issuer ticker: TIL
Reported as of: 04 Mar 2022
Net transaction value: +$2,111,900
SEC form: 4
Accepted by SEC: 07 Mar 2022, 16:10:14 UTC
Prior SEC filing: 08 Oct 2021
Next SEC filing: 09 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Sandeep Laumas, M.D. Attorney-in-Fact for Zachary Roberts

Key filing fact

Zachary Roberts filed Form 4 for Instil Bio, Inc. (TIL) on 07 Mar 2022.

Key facts

This page summarizes Zachary Roberts's Form 4 filing for Instil Bio, Inc. (TIL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Mar 2022, 16:10.

Change

Previous filing in this sequence was filed on 08 Oct 2021.
Current net transaction value: +$2,111,900.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TIL transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $2,111,900
Shares: +245,000
Change %
Price: $8.62^*
Shares after: 245,000
Date: 04 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 245,000
Exercise price: $8.62
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.